IRF8_VAX2

CAP-SELEX sample VAX2_IRF8 · 1 runs in PRJEB66722

Organism
Nucleic acid
DNA
Rounds available
R3
Sequences indexed
10,000

Top enriched sequences

More via API →
Sequence Length log2 FC P(active) Class Monotonicity
CGCACTTAAACTCGAAAGCATGCCATCGAAACCGAAACAC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:93be9abd26ee
40
GTGATCAAGTGGTCTCTGGCGACCGAAACTGAAACAATGC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:58e9d7c06594
40
GCATGAAACCGAAAGCAACGATCCCATAGGAGACAGCAAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:9f1cfd7f0435
40
CCGGTGCGACCAACGAAACTGAAACCCCATTAACCTCAAT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:1b117e84d0c1
40
CTTGAACCAGGGCGATAACGAAACCGAGAGCAATTAGCAC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:f31ef1c78f92
40
CGGACGCGTCCCCGCTGTACGAAAGCGAAACTACTTAGGC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:cdfa958df985
40
TCGACCTTGCCTCGAAACCGATACTACTCTAATTAGCCGC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:71c3c5ca769f
40
TGCATATTAACATGGTTTCGATATTGGTATCGAAAGTGAG
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:a071e522dffa
40
ACGCCAACCGAAACTGAAAGCAATTAACCAAGCCACGTTG
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:4813cf8cb6fc
40
TCCGAAAGTGAAACCGCACCAATTACGACATGATTTCCAC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:b1d57789c60d
40
TGACCCACTAAGTACTCGCGCTGGTGCAGGCGAAACCGAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:e80126c6298e
40
CCTCCTGCCAAACATATGTTGACGGACAACGCCTTCCGAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:14813f2d47c3
40
GCGGGTGGCGATGTAACGAAACCGATACTACGTAATTAGT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:5ba8d0792d87
40
CATCAGGCGGAACGAAACTGAAACAAGGTTAATGACACGC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:542b00252bd1
40
GGCTTGACACAAGAAGTCTGCCATGCTTGTCGAAAGCGAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:c5b18acd9961
40
TGATGCCCTAATGAACAGTTTCGCTACCATGTAAACCGCA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:8126bf7b3d8c
40
CATCCCACCAACTACTGAAACCGAAACTGCCTCATTAGCG
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:265c7d83e9bf
40
TCCTGCTTTTCCCACTTAATGACTTTCACTTTCATACCGT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:491a5c61df2e
40
CGAAACCGAAACGGCACATTAGCATAATTCGCATAGTCCG
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:742e741ee3d3
40
CGAAACTGAAAGTCATTATGCGCAACAGATTGGTTAGTCA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:96579a8803fa
40
CCGAAACTAGCGGCCAACGTGAAACCATCGCTAATTGCTC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:c77be97c3796
40
ACGAAACCGAAACCTAATCAAGCTAATTGCACCACCCTCC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:395d5cbafaaf
40
GTCCCGACGAACGAAAGTGAATCTATCCCATTAGCGCGTA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:feaf8838215a
40
TTACCAAGTTTCGGTTTCACCAAAGCCACAATTAAGGCGC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:466ffd8330fc
40
CTCATGCCGAATCGAAAGTAATCATGCAAGTTTCGACGGT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:2556e50e95fe
40
ATCGAAACCACATCGTTCGTCCTGGCGAAACTACTTACCA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:1638dc28c800
40
AAACGAAACCAAAACTGCGTAATTAAGGCCAGTCTGCAGT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:bb5d8cec3b78
40
CCGATTAGTGCAGCGAAACTGAAACTCATTACACTAGGAC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:e5dc90f05a9e
40
CCATCGAAACTACGTCAGCCATACCGAAAGTAATCTCCGG
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:15355cb8cf2e
40
ATGCATCGAAAGTGAAAGTTAGTGATTAGCGTGTCGTTAT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:c89e45311f79
40
TGAAACCGAATCACGAAACTACATCATTAACACCTTCGAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:3a6311f503e7
40
GCGAAACCTTGTCGTGAAACCGAAACAACGAAATTACCGT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:92c7b2dc8bfb
40
CAACCGCTAAGTACTTTCGGTTTCTATCTAGTTGACCACG
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:e6a3e77ab57b
40
GTGTGCCATATACTGAAACCGAAACTGACACTATTACCAC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:682966e47a94
40
TGTTGACAGAAGACGAAACTAACACCGAAACTAATTACAC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:e08cd1527877
40
TGAGCTTGAAACCGAAACTGCACAACACCCACTTAATGAC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:fbd56291c29f
40
TACCACCAAAACGAAAGCGCAACTCATTAACGCGTACATT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:b6ddf8cc6c46
40
GTGTAATGACGTTTCAGTTTCGTTTTCCTACCGCGCGCAT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:c95d66401745
40
ACCGTTAGATCCATCGAAACTACTTATGACAGCAATCGAT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:70fce64d1d37
40
TCACTTTCGATTATAACGCAACCCATGACCTCACATCGAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:e0747d97b21c
40
GTCCGAAACTAATGACGCGTCAATTACCGCGCGTATCGAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:8642a1916151
40
CACTGAAACTGAAACTACTAATTGCTTCGCTGACCCTAAT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:64563c57992f
40
CACACGCGAAAGCGAAACTTCGCTCATTAACGCGCACTAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:2857b6694ae7
40
TTAGGCTTAACCACCTCATTGCGCTGTTCGTGAAACTGAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:f8a09a9da734
40
TTACTTCCGGTTTCGATACTCAGTGCATATACCTCATTTC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:46a289fd3085
40
AGTATCGAAACACACAATCGAAACTGCGAGATTAGCAGTT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:0c431ce00989
40
GCCCACTATCCCATGAAACCACGTAATTACCAGCAACGAA
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:638220814697
40
CTAATTGCTTTCACTTTCCATCCATAACGATACTCCCTAT
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:ad58123c3170
40
AGTGCGCAAGGGTAAACCGAAACCGATACCTCATTACAGC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:9a9aaf6d3fbe
40
GACCATTGCTGACATTGAAACCGAAAGTCATTAAGCGTTC
PANAPTA:Q02556:IRF8_VAX2:PRJEB66722:R3:e62ab7cac187
40

SELEX rounds

R3 ·final